Search

Author/Creator Fisher, Joy

1. ACTR-14. PHASE I STUDY OF AZD1775 WITH RADIATION THERAPY (RT) AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) AND EVALUATION OF INTRATUMORAL DRUG DISTRIBUTION (IDD) IN PATIENTS WITH RECURRENT GBM. (5th November 2018)

Authors:
Alexander, Brian; Supko, Jeffrey; Agar, Nathalie; Ahluwalia, Manmeet; Desai, Arati; Dietrich, Jorg; Kaley, Thomas; Peereboom, David; Takebe, Naoko; Desideri, Serena; Fisher, Joy; Sims, Megan; Ye, Xiaobu; Ligon, Keith; Nabors, L Burt; Grossman, Stuart; Wen, Patrick
Journal:
Neuro-oncology
Issue:
Volume 20(2018)Supplement 6
Page Start:
vi13
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. ACTR-58. BASELINE REQUIREMENTS FOR NOVEL AGENTS BEING CONSIDERED FOR BRAIN CANCER EFFICACY TRIALS: REPORT OF AN ABTC WORKSHOP. (11th November 2019)

Authors:
Grossman, Stuart; Romo, Carlos; Rudek-Renaut, Michelle; Supko, Jeffrey; Fisher, Joy; Nabors, Burt; Wen, Patrick; Peereboom, David; Ellingson, Benjamin; Ye, Xiaobu
Journal:
Neuro-oncology
Issue:
Volume 21(2019)Supplement 6
Page Start:
vi27
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Baseline requirements for novel agents being considered for phase II/III brain cancer efficacy trials: conclusions from the Adult Brain Tumor Consortium's first workshop on CNS drug delivery. Issue 10 (7th June 2020)

Authors:
Grossman, Stuart A; Romo, Carlos G; Rudek, Michelle A; Supko, Jeffrey; Fisher, Joy; Nabors, L Burt; Wen, Patrick Y; Peereboom, David M; Ellingson, Benjamin M; Elmquist, William; Barker, Fred G; Kamson, David; Sarkaria, Jann N; Timmer, William; Bindra, Ranjit S; Ye, Xiaobu
Journal:
Neuro-oncology
Issue:
Volume 22:Issue 10(2020)
Page Start:
1422
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. CTNI-07. ABTC-1701: PILOT SURGICAL PK STUDY OF BGB324 (BEMCENTINIB) IN RECURRENT GLIOBLASTOMA PATIENTS – RESULTS FROM INTERIM FUTILITY ANALYSIS. (12th November 2021)

Authors:
Burt Nabors, L; Nakano, Ichiro; Supko, Jeff; Lobbous, Mina; Grossman, Stuart; Ye, Xiaobu; Desideri, Serena; Danda, Neeraja; Fisher, Joy; Strowd, Roy; Walbert, Tobias
Journal:
Neuro-oncology
Issue:
Volume 23: Supplement 6(2021)
Page Start:
vi60
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. CTNI-18. PHASE I AND PRELIMINARY PHASE 0 RESULTS OF ABTC 1801: A MULTI-ARM CLINICAL TRIAL OF THE PARP INHIBITOR PAMIPARIB (BGB290) WITH VERY LOW DOSE METRONOMIC TEMOZOLOMIDE IN RECURRENT IDH MUTANT GLIOMAS. (12th November 2021)

Authors:
Schiff, David; Bindra, Ranjit; Li, Jing; Ye, Xiaobu; Ellingson, Benjamin; Walbert, Tobias; Campian, Jian; Nabors, L Burt; Lieberman, Frank; Ozer, Byran; Desai, Arati; Omuro, Antonio; Wen, Patrick; Desideri, Serena; Fisher, Joy; Grossman, Stuart
Journal:
Neuro-oncology
Issue:
Volume 23: Supplement 6(2021)
Page Start:
vi63
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. CTNI-26. SURGICAL WINDOW OF OPPORTUNITY TRIAL OF NAVTEMADLIN (KRT 232; AMG232) IN PATIENTS WITH RECURRENT GLIOBLASTOMA. (14th November 2022)

Authors:
Lee, Eudocia; Rudek, Michelle; Rendo, Veronica; Khuu, Nicholas; Walbert, Tobias; Holdhoff, Matthias; Lieberman, Frank; Desai, Arati; Strowd, Roy; Lapinskas, Emily; Pelton, Kristine; Pisano, William; Desideri, Serena; Danda, Neeraja; Fisher, Joy; Ye, Xiaobu; Nabors, L Burt; Grossman, Stuart; Berou...
Journal:
Neuro-oncology
Issue:
Volume 24(2022)Supplement 7
Page Start:
vii76
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. CTNI-60. PRELIMINARY RESULTS OF BINIMETINIB AND ENCORAFENIB IN ADULTS WITH RECURRENT BRAF V600E-MUTATED HIGH-GRADE GLIOMA. (14th November 2022)

Authors:
Schreck, Karisa; Strowd, Roy; Nabors, L Burt; Ellingson, Ben; Fisher, Joy; Desideri, Serena; Danda, Neeraja; Rudek, Michelle; Grossman, Stuart; Ye, Xiaobu
Journal:
Neuro-oncology
Issue:
Volume 24(2022)Supplement 7
Page Start:
vii86
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. DDEL-11. DETERMINING THE DOSE OF REGADENOSON MOST LIKELY TO TRANSIENTLY ALTER THE INTEGRITY OF THE BLOOD-BRAIN BARRIER IN PATIENTS WITH GLIOMAS. (14th November 2022)

Authors:
Romo, Carlos; Ellingson, Benjamin; Strowd, Roy; Lesser, Glenn; Raymond, Catalina; Kral, Brian; Ye, Xiaobu; Desideri, Serena; Fisher, Joy; Grossman, Stuart
Journal:
Neuro-oncology
Issue:
Volume 24(2022)Supplement 7
Page Start:
vii96
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. IMMU-18. IMMUNOGENOMIC RESPONDER PHENOTYPE FROM A PHASE I TRIAL OF ANTI-LAG3 OR ANTI-CD137 ALONE AND IN COMBINATION WITH ANTI-PD-1 IN PATIENTS WITH RECURRENT GBM. (11th November 2019)

Authors:
Jackson, Christina; Choi, John; Zhang, JiaJia; Piotrowski, Anna; Walbert, Tobias; Desai, Arati; Ahluwalia, Manmeet; Nabors, Burt; Ye, Xiaobu; Desideri, Serena; Fisher, Joy; Wen, Patrick; Grossman, Stuart; Smith, Kellie; Pardoll, Drew; Lim, Michael
Journal:
Neuro-oncology
Issue:
Volume 21(2019)Supplement 6
Page Start:
vi122
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗